Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection
Keywords:
Surfactant, pneumonia, premature nonatesAbstract
Introduction: Surfactant inactivation is present in neonatal pneumonia. Materials and Methods: One hundred thirty-nine preterm babies with BirthWeight (BW) ≤ 1250 grams were studied and subdivided in two groups: RDS Group, with a diagnosis of “simple” RDS (N 80) and RDS with Pneumonia Group, consisting of babies with a diagnosis of RDS and a positive BALF culture in the first 24-48 h of life (N 59). Outcomes: Surfactant administration seems less effective in the latter group, because a significantly higher number of infants needed a second dose of surfactant, compared to the patients suffering from RDS alone.
Downloads
Published
01-07-2012
Issue
Section
Session 2 – Exogenous surfactant in neonatology
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
1.
Vento G, Tana M, Tirone, et al. C. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection. Acta Biomed. 2012;83(1):36-39. Accessed February 24, 2025. https://mattioli1885journals.com/index.php/actabiomedica/article/view/2362
